BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4149375)

  • 1. DPNH synergism of TPNH-dependent mixed function oxidase reactions.
    Correia MA; Mannering GJ
    Drug Metab Dispos; 1973; 1(1):139-49. PubMed ID: 4149375
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. I. Effects of activation and inhibition of the fatty acyl coenzyme A desaturation system.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):455-69. PubMed ID: 4146889
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxidative drug metabolism in human liver microsomes.
    Nelson EB; Raj PP; Belfi KJ; Masters BS
    J Pharmacol Exp Ther; 1971 Sep; 178(3):580-8. PubMed ID: 4398379
    [No Abstract]   [Full Text] [Related]  

  • 5. Sex-dependent differences in drug metabolism in the rat. I. Temporal changes in microsomal drug-metabolizing system of the liver during sexual maturation.
    el-Masry S el-D ; Cohen GM; Mannering GJ
    Drug Metab Dispos; 1974; 2(3):267-78. PubMed ID: 4153058
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyridine nucleotide transhydrogenases.
    Kaplan NO
    Harvey Lect; 1971-1972; 66():105-33. PubMed ID: 4403442
    [No Abstract]   [Full Text] [Related]  

  • 7. Microsomal electron transport reactions. II. The use of reduced triphosphopyridine nucleotide and-or reduced diphosphopyridine nucleotide for the oxidative N-demethylation of aminopyrine and other drug substrates.
    Cohen BS; Estabrook RW
    Arch Biochem Biophys; 1971 Mar; 143(1):46-53. PubMed ID: 4397837
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced cytochrome c as an electron donor for microsomal mixed-function oxidase reactions.
    Wahle KW; Davies NT
    Proc Nutr Soc; 1977 May; 36(1):29A. PubMed ID: 19743
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytochrome oxidase activity and reduction capacity of ascites tumours.
    Banga I; Mayláth-Palágyi J; Lapis K
    Acta Physiol Acad Sci Hung; 1971; 39(1):81-92. PubMed ID: 4330187
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethanol-induced changes in levels of metabolites related to the redox state and ketogenesis in rat liver.
    Lindros KO; Aro H
    Ann Med Exp Biol Fenn; 1969; 47(1):39-42. PubMed ID: 4391402
    [No Abstract]   [Full Text] [Related]  

  • 11. An approach measurement of the stoichiometric relationship between hepatic microsomal drug metabolism and the oxidation of reduced nicotinamide adenine dinucleotide phosphate.
    Stripp B; Zampaglione N; Hamrick M; Gillette JR
    Mol Pharmacol; 1972 Mar; 8(2):189-96. PubMed ID: 4402003
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition by cyanide of drug oxidations in rat liver microsomes.
    Kitada M; Chiba K; Kamataki T; Kitagawa H
    Jpn J Pharmacol; 1977 Oct; 27(5):601-8. PubMed ID: 22768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stoichiometry of aminopyrine demethylation with and without NADH synergism.
    Jansson I; Schenkman JB
    Drug Metab Dispos; 1981; 9(5):461-5. PubMed ID: 6117446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of drug biotransformation reactions in the placenta.
    Juchau MR
    Fed Proc; 1972; 31(1):48-51. PubMed ID: 4550597
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of temperature and substrates on component reactions of the hepatic microsomal mixed-function oxidase.
    Schenkman JB
    Mol Pharmacol; 1972 Mar; 8(2):178-88. PubMed ID: 4402002
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mechanism of sex difference in drug-oxidizing activity of liver microsomes.
    Kato R; Takanaka A; Takayanagi M
    Jpn J Pharmacol; 1968 Dec; 18(4):482-9. PubMed ID: 4388258
    [No Abstract]   [Full Text] [Related]  

  • 17. A requirement for lipids by the microsomal stearyl coenzyme A desaturase.
    Jones PD; Holloway PW; Peluffo RO; Wakil SJ
    J Biol Chem; 1969 Feb; 244(4):744-54. PubMed ID: 4388795
    [No Abstract]   [Full Text] [Related]  

  • 18. NADH synergism of microsomal aniline metabolism in the presence of enhancing agents.
    Powis G; Lyon L; McKillop D
    Biochem Pharmacol; 1977 Jan; 26(2):137-41. PubMed ID: 13799
    [No Abstract]   [Full Text] [Related]  

  • 19. Biphasic oxidation of mitochondrial NAD(P)H.
    Lemeshko VV
    Biochem Biophys Res Commun; 2002 Feb; 291(1):170-5. PubMed ID: 11829479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the use of nicotinamide in assays for microsomal mixed-function oxidase activity.
    Schenkman JB; Ball JA; Estabrook RW
    Biochem Pharmacol; 1967 Jun; 16(6):1071-81. PubMed ID: 4382738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.